Endothelial function. General considerations

Drugs

Volumn 53, Issue SUPPL. 1, 1997, Pages 1-10

  Haller, Hermann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; DIHYDROPYRIDINE DERIVATIVE; ENDOTHELIN 1; IMMUNOGLOBULIN; INTEGRIN; NITRENDIPINE; NITRIC OXIDE; PROSTACYCLIN; SELECTIN; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL; BLOOD VESSEL TONE; CELL ACTIVATION; CELL ADHESION; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL STRUCTURE; CONFERENCE PAPER; DIABETES MELLITUS; ENDOTHELIUM; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LEUKOCYTE MIGRATION; MONOCYTE; MULTIGENE FAMILY; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; THROMBOCYTE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0031046435     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199700531-00003     Document Type: Conference Paper

References (78)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504
2. Gordon D, Reidy MA, Benditt EP, et al. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990; 87: 4600-4
3. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993; 71 (6): 21-9
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9
5. Luscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton: CRC Press, 1990
6. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 1988; 62: 30-35G
7. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 1: 997-1000
8. Luscher TF. Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension? Am J Hypertens 1990; 3: 317-30
9. Palmer RJM, Ashtor DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6
10. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus: call for data. Diabetes 1991; 40: 653-9
11. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, et al. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461-3
12. Guerra R, Brotherton AFA, Goodwill PJ, et al. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF. Blood Vessels 1989; 26: 300-14
13. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 388: 411-5
14. Panza JA, Quyyumi AA, Brush Jr JE, et al. Endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7
15. Yang Z, Richard V, von Segesser L, et al. Threshold concentrations of endothelin-1 potentiate contractons to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation 1990; 82: 188-95
16. Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes melllitus. Semin Thromb-Hemost 1991; 17 (4): 422-5
17. DiCorleto PE, Fox PL. Growth factor production by endothelial cells. In: Endothelial cells. Vol. 2. Una R, editor. Boca Raton: CRC Press, 1988: 51-62
18. Egleme C, Creesier F, Wood JM. Local formation of angiotensin II in the rat aorta: effect of endothelium. Brit J Pharmacol 1990; 100: 237-40
19. Davi G, Rini GB, Averna M, et al. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. Thromb Res 1982; 26: 359-70
20. Butkus A, Srinska VA, Schumacher OP. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 1980; 19: 211-23
21. Yamouchi T, Ohnaka K, Takayanagi R, et al. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 1990; 267: 16-8
22. Williams E, Timperley WR, Ward JD, et al. Electron microscopic studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980; 33: 462
23. Vracko R. A comparison of the microvascular lesions in diabetic mellitus with those of normal aging. J Am Geriatr Soc 1982; 30: 201-5
24. DiCorleto PE, Chisolm GM. Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res 1986; 25: 365-74
25. Meraji S, Jayakody L, Senaratne MP, et al. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 1987; 36: 978-81
26. Tesfamariam B, Brown ML, Deykin D, et al. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990; 85: 929-32
27. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-18
28. Berk BC, Alexander RW, Brock TA, et al. Vasoconstriction - a new role for platelet-derived growth factor. Science 1986; 232: 87-90
29. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51
30. Panza JA, Quyyumi AA, Brush Jr JE, et al. Endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7
31. Simionescu M, Simionescu N. Functions of the endothelial cell surface. Ann Rev Physiol 1986; 48: 279-304
32. Scharf RE, Harker LA. Thrombosis and atherosclerosis: regulatory role of interactions among blood components and endothelium. Blut 1987; 55: 131
33. Springer TA. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Ann Rev Cell Biol 1990; 6: 359-402
34. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the non-human primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1986; 4: 323-40
35. Gerrity RG. The role of monocyte in atherogenesis. I. Transition of bloodborne tnonocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-90
36. Cybulsky MI, Gimbrone MJ. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251 (4995): 788-91
37. Li H, Cybulsky MI, Gimbrone MJ, et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993; 13 (2): 197-204
38. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991; 64: 5-15
39. Alderson LM, Endemann G, Lindsey S, et al. LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol 1986; 123: 334-41
40. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified LDL stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260-7
41. Frostegard J, Haegerstrand A, Gidlund M, et al. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 1991; 90 119-26
42. Kume N, Cybulsky MI, Gimbrone MJ. Lysophosphatidylcholine, a component of atherogenic lipoproleins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90 (3): 1138-44
43. Haller H, Schaper D, Philipp S, et al. LDL induces surface expression of adhesion molecules ICAM-1 and VCAM on endothelial cells via the activation of protein kinase C. J Am Soc Nephrol 1992; 3: 456
44. Gilcrease MZ, Hoover RL. Examination of monocyte adherence to endothelium under hyperglycaemic conditions. Am J Pathol 1991; 139: 1089-97
45. DiCorleto PE. Cellular mechanisms of atherogenesis. Am J Hypertension 1993; 6: 314-18S
46. Schaberg T, Rau M, Kaiser D, et al. Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects: association with cell-binding ability and superoxide union production. Am Rev Respir Dis 1992; 146: 1287-93
47. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21
48. Vlassara H, Brownlee M, Monogue K, et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 1988; 240: 1546-8
49. Esposito C, Gerlach H, Brett J, et al. Endothelial receptor mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170: 1387-407
50. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36: 319-27
51. King GL, Goodman AD, Buzney S, et al. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75: 1028-36
52. Weinstein R, Stemerman MB, Maciag T. Hormonal requirements for growth of arterial smooth muscle cells in vitro: an endocrine approach to atherosclerosis. Science 1981; 212: 818-20
53. Capron L, Jarnet J, Kazandjian S, et al. Growth-promoting effects of diabetes and insulin on arteries: an in vivo study of rat aorta. Diabetes 1986; 35: 973-8
54. Stout RW. Insulin and atheroma. 20-yr perspective. Diabetes Care 1990; 13: 631-54
55. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin induced glomerular thrombosis. J Clin Invest 1990; 90: 1718-25
56. Steiner G. Diabetes and atherosclerosis: an overview. Diabetes 1981; 30 Suppl. 2: 1-7
57. Cagliero E, Maiello M, Boeri D, et al. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988; 82: 735-8
58. Ciriaco E, Abbate F, Ferrante F, et al. Structural changes in the endothelium of the femoral artery of spontaneously hypertensive rats: sensitivity to isradipine treatment. J Hypertens 1993; 11: 515-22
59. Himmel HM, Whorton AR, Strauss HC. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension 1993; 21: 112-27
60. Gunther J, Dhein S, Rosen R, et al. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries. Basic Res Cardiol 1992; 87: 452-60
61. Wilkie ME, Stevens CR, Cunningham J, et al. Hypoxia-induced von Willebrand factor release is blocked by verapamil. Miner Electrolyte Metab 1992; 18: 141-4
62. Luscher TF, Espinosa E, Dubey RK, et al. Vascular biology of human coronary artery and bypass graft disease. Curr Opin Cardiol 1993; 8: 963-74
63. Yang Z, Bauer E, von Segesser L, et al. Different mobilization of calcium in endothelin-1-induced contractions in human arteries and veins: effects of calcium antagonists. J Cardiovasc Pharmacol 1990; 16: 654-66
64. Goto K, Kasuya Y, Matsuki N, et al. Endothelin activates the dihydropyridine-sensitive, voltage-dependent calcium channel in vascular smooth muscle. Proc Natl Acad Sci USA 1989; 86: 3915-8
65. Kiowski W, Luscher TF, Linder L, et al. Endothelin-1 induced vasocontriction in man: reversal by calcium channel blockade but not by nitrovasodilators or EDRF. Circulation 1991; 83: 469-75
66. 2-production in human alveolar macrophages. Am J Physiol 1991; 261: L478-84
67. Wright B, Zeidman I, Greig R, et al. Inhibition of macrophage function by calcium channel blockers and calmodulin antagonists. Cell Immunol 1985; 95: 46-53
68. Jouvin-Marche E, Cerrina J, Coeffier E, et al. Effect of the calcium antagonist nifedipine on the release of PAF, slow-reacting substance and beta-glucuronidase from human neutrophils. Eur J Pharmacol 1983; 89: 19-26
69. Tschope D, Kaufmann L, Roesen P, et al. Influence of a single dose of nitrendipine on whole platelet activity in healthy subjects. J Cardiovasc Pharmacol 1988; 12: S167-9
70. Rostagno C, Abbate R, Gensini GF, et al. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium distribution, platelet aggregation and thromboxane A2 formation. Thromb Res 1991; 63: 457-62
71. Haller H, Lenz T, Ludersdorf M, et al. Changes in sensitivity to angiotensin II in platelets. J Cardiovasc Pharmacol 1987; 10 Suppl. 10: S44-6
72. McDonagh PF, Rauzzino MJ. Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist. Am J Physiol 1993; 265: H476-83
73. Collins P, Rosano GM, Jiang C, et al. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 1993; 341: 1264-5
74. Fleckenstein-Grun G, Frey M, Thimm F, et al. Calcium overload - an important cellular mechanism in hypertension and arteriosclerosis. Drugs 1992; 44 Suppl. 1: 23-30
75. Haller H. Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis. Am J Kidney Dis 1993; 21: 26-31
76. Borcherding SM, Meeves SG, Klutman NE, et al. Calcium-channel antagonists for prevention of atherosclerosis. Ann Pharmacother 1993; 27: 61-7
77. Lichtlen PR, Hugenholtz PG, Rafflenbeul W. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT). Lancet 1990; 335: 1109-13
78. Waters D, Lesperance J, Francetich M. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940-53